J&J gets Closure
This article was originally published in The Tan Sheet
Executive Summary
Manufacturer of Band-Aid Liquid Bandage and Dermabond topical adhesive is being acquired by Johnson & Johnson in a cash-for-stock exchange worth roughly $370 mil., the firms announce March 4. Closure will operate as a stand-alone entity reporting through J&J division Ethicon. Liquid Band-Aid sales grew roughly 20% over the prior-year period due to the domestic launch of the Skin Crack Gel line extension. However, sales were negatively impacted by private-label competition. J&J will incur a one-time, after-tax charge of $68 mil.; Closure shareholders will receive $27 for each outstanding share. The addition to the device unit closely follows J&J's purchase of Guidant in December...
You may also be interested in...
J&J Closure acquisition
Johnson & Johnson has completed its acquisition of Closure Medical, the firm announces June 3. The Band-Aid Liquid Bandage and Dermabond topical adhesive maker is being purchased for $370 mil., J&J said when announcing the merger in March (1"The Tan Sheet" March 7, 2005, In Brief)...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.